A look into the future of ALS research

Drug Discovery Today

Volumn 21, Issue 6, 2016, Pages 939-949

  Clerc, Pascaline ^a   Lipnick, Scott ^b   Willett, Catherine ^a  

^a Humane Society of the United States   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYOTROPHIC LATERAL SCLEROSIS; DEGENERATIVE DISEASE; DISEASE COURSE; DISEASE PREDISPOSITION; EXPERIMENTAL MODEL; GENE OVEREXPRESSION; GENETIC ANALYSIS; GENETIC ASSOCIATION; HISTOLOGY; HUMAN; MEDICAL RESEARCH; METHODOLOGY; NONHUMAN; OUTCOME ASSESSMENT; PHENOTYPE; PREDICTIVE VALUE; REVIEW; SPINAL CORD DISEASE; TREATMENT PLANNING; ANIMAL; DISEASE MODEL;

AMYOTROPHIC LATERAL SCLEROSIS; ANIMALS; BIOMEDICAL RESEARCH; DISEASE MODELS, ANIMAL; HUMANS;

EID: 84958191246     PISSN: 13596446     EISSN: 18785832     Source Type: Journal    
DOI: 10.1016/j.drudis.2016.02.002     Document Type: Review

References (107)

1. A.M. Vincent, and et al. Strategic approaches to developing drug treatments for ALS Drug Discov. Today 13 2008 67 72
2. S. Zhu, and et al. Minocycline inhibits cytochrome c release and delays progression of amyotrophic lateral sclerosis in mice Nature 417 2002 74 78
3. J.J. Sejvar, and et al. Amyotrophic lateral sclerosis mortality in the United States, 1979-2001 Neuroepidemiology 25 2005 144 152
4. F. Kamel, and et al. Pesticide exposure and amyotrophic lateral sclerosis Neurotoxicology 33 2012 457 462
5. N.A. Sutedja, and et al. Exposure to chemicals and metals and risk of amyotrophic lateral sclerosis: a systematic review Amyotroph. Lateral Scler. 10 2009 302 309
6. R.W. Haley Excess incidence of ALS in young Gulf War veterans Neurology 61 2003 750 756
7. D.R. Rosen, and et al. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis Nature 362 1993 59 62
8. D.R. Borchelt, and et al. Superoxide dismutase 1 with mutations linked to familial amyotrophic lateral sclerosis possesses significant activity Proc. Natl. Acad. Sci. U. S. A. 91 1994 8292 8296
9. R.L. Redler, and N.V. Dokholyan The complex molecular biology of amyotrophic lateral sclerosis (ALS) Progr. Mol. Biol. Transl. Sci. 107 2012 215 262
10. T. Murakami, and et al. A novel SOD1 gene mutation in familial ALS with low penetrance in females J. Neurol. Sci. 189 2001 45 47
11. A.E. Renton, and et al. A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD Neuron 72 2011 257 268
12. M. Neumann, and et al. Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis Science 314 2006 130 133
13. E. Kabashi, and et al. TARDBP mutations in individuals with sporadic and familial amyotrophic lateral sclerosis Nat. Genet. 40 2008 572 574
14. B.D. Freibaum, and et al. Global analysis of TDP-43 interacting proteins reveals strong association with RNA splicing and translation machinery J. Proteome Res. 9 2010 1104 1120
15. H. Zinszner, and et al. TLS (FUS) binds RNA in vivo and engages in nucleo-cytoplasmic shuttling J. Cell Sci. 110 1997 1741 1750
16. M.E. Gurney, and et al. Motor neuron degeneration in mice that express a human Cu,Zn superoxide dismutase mutation Science 264 1994 1772 1775
17. D.A. Bosco, and et al. Wild-type and mutant SOD1 share an aberrant conformation and a common pathogenic pathway in ALS Nat. Neurosci. 13 2010 1396 1403
18. M. Benatar Lost in translation: treatment trials in the SOD1 mouse and in human ALS Neurobiol. Dis. 26 2007 1 13
19. E. Culetto, and D.B. Sattelle A role for Caenorhabditis elegans in understanding the function and interactions of human disease genes Hum. Mol. Genet. 9 2000 869 877
20. M.R. Watson, and et al. A drosophila model for amyotrophic lateral sclerosis reveals motor neuron damage by human SOD1 J. Biol. Chem. 283 2008 24972 24981
21. R. Lemmens, and et al. Overexpression of mutant superoxide dismutase 1 causes a motor axonopathy in the zebrafish Hum. Mol. Genet. 16 2007 2359 2365
22. J. Lladó, and et al. Degeneration of respiratory motor neurons in the SOD1 G93A transgenic rat model of ALS Neurobiol. Dis. 21 2006 110 118
23. A. Uchida, and et al. Non-human primate model of amyotrophic lateral sclerosis with cytoplasmic mislocalization of TDP-43 Brain 135 2012 833 846
24. T. Awano, and et al. Genome-wide association analysis reveals a SOD1 mutation in canine degenerative myelopathy that resembles amyotrophic lateral sclerosis Proc. Natl. Acad. Sci. U. S. A. 106 2009 2794 2799
25. M.J. Crisp, and et al. Canine degenerative myelopathy: biochemical characterization of superoxide dismutase 1 in the first naturally occurring non-human amyotrophic lateral sclerosis model Exp. Neurol. 248 2013 1 9
26. M. Ogawa, and et al. Immunohistochemical observation of canine degenerative myelopathy in two Pembroke Welsh Corgi dogs J. Vet. Med. Sci. 73 2011 1275 1279
27. L. Kinsley, and T. Siddique Amyotrophic lateral sclerosis overview Gene Rev 1993
28. P.A. McCombe, and R.D. Henderson Effects of gender in amyotrophic lateral sclerosis Gender Med. 7 2010 557 570
29. J.R. Coates, and et al. Clinical characterization of a familial degenerative myelopathy in Pembroke Welsh Corgi dogs J. Vet. Intern. Med. 21 2007 1323 1331
30. J. Wang, and et al. An ALS-linked mutant SOD1 produces a locomotor defect associated with aggregation and synaptic dysfunction when expressed in neurons of Caenorhabditis elegans PLoS Genet. 5 2009 e1000350
31. T. Ramesh, and et al. A genetic model of amyotrophic lateral sclerosis in zebrafish displays phenotypic hallmarks of motoneuron disease Dis. Models Mech. 3 2010 652 662
32. I.R.A. Mackenzie, and et al. Pathological TDP-43 distinguishes sporadic amyotrophic lateral sclerosis from amyotrophic lateral sclerosis with SOD1 mutations Ann. Neurol. 61 2007 427 434
33. B.J. Turner, and et al. TDP-43 expression in mouse models of amyotrophic lateral sclerosis and spinal muscular atrophy BMC Neurosci. 9 2008 104
34. C. Lagier-Tourenne, and D.W. Cleveland Rethinking ALS: the FUS about TDP-43 Cell 136 2009 1001 1004
35. A.C. Elden, and et al. Ataxin-2 intermediate-length polyglutamine expansions are associated with increased risk for ALS Nature 466 2010 1069 1075
36. E. Kabashi, and et al. Gain and loss of function of ALS-related mutations of TARDBP (TDP-43) cause motor deficits in vivo Hum. Mol. Genet. 19 2010 671 683
37. I. Wegorzewska, and et al. TDP-43 mutant transgenic mice develop features of ALS and frontotemporal lobar degeneration Proc. Natl. Acad. Sci. U. S. A. 106 2009 18809 18814
38. N.R. Stallings, and et al. Progressive motor weakness in transgenic mice expressing human TDP-43 Neurobiol. Dis. 40 2010 404 414
39. V. Swarup, and et al. Pathological hallmarks of amyotrophic lateral sclerosis/frontotemporal lobar degeneration in transgenic mice produced with TDP-43 genomic fragments Brain 134 2011 2610 2626
40. T.F. Gendron, and et al. TARDBP mutation analysis in TDP-43 proteinopathies and deciphering the toxicity of mutant TDP-43 J. Alzheim. Dis. 33 Suppl. 1 2013 S35 S45
41. I.R. Mackenzie, and et al. TDP-43 and FUS in amyotrophic lateral sclerosis and frontotemporal dementia Lancet Neurol. 9 2010 995 1007
42. T.J. Kwiatkowski, and et al. Mutations in the FUS/TLS gene on chromosome 16 cause familial amyotrophic lateral sclerosis Science 323 2009 1205 1208
43. T. Murakami, and et al. ALS mutations in FUS cause neuronal dysfunction and death in Caenorhabditis elegans by a dominant gain-of-function mechanism Hum. Mol. Genet. 21 2012 1 9
44. Y. Chen, and et al. Expression of human FUS protein in Drosophila leads to progressive neurodegeneration Protein Cell 2 2011 477 486
45. E. Kabashi, and et al. FUS and TARDBP but not SOD1 interact in genetic models of amyotrophic lateral sclerosis PLoS Genet. 7 2011 e1002214
46. C. Huang, and et al. FUS transgenic rats develop the phenotypes of amyotrophic lateral sclerosis and frontotemporal lobar degeneration PLoS Genet. 7 2011 e1002011
47. J.C. Mitchell, and et al. Overexpression of human wild-type FUS causes progressive motor neuron degeneration in an age- and dose-dependent fashion Acta Neuropathol. 125 2013 273 288
48. J. Schnabel Neuroscience: standard model Nature 454 2008 682 685
49. G.R. Langley Considering a new paradigm for Alzheimer's disease research Drug Discov. Today 19 2014 1114 1124
50. G.L. Buckland Harnessing opportunities in non-animal asthma research for a 21st-century science Drug Discov. Today 16 2011 914 927
51. A.R. Muotri The human model: changing focus on autism research Biol. Psychiatry 2015 10.1016/j.biopsych.2015.03.012
52. L.J. Martin, and et al. Motor neuron degeneration in amyotrophic lateral sclerosis mutant superoxide dismutase-1 transgenic mice: mechanisms of mitochondriopathy and cell death J. Comp. Neurol. 500 2007 20 46
53. N. Shibata Transgenic mouse model for familial amyotrophic lateral sclerosis with superoxide dismutase-1 mutation Neuropathology 21 2001 82 92
54. M.C. Dal Canto, and M.E. Gurney Neuropathological changes in two lines of mice carrying a transgene for mutant human Cu,Zn SOD, and in mice overexpressing wild type human SOD: a model of familial amyotrophic lateral sclerosis (FALS) Brain Res. 676 1995 25 40
55. A. Henriques, and et al. Characterization of a novel SOD-1(G93A) transgenic mouse line with very decelerated disease development PLoS One 5 2010 e15445
56. G.M. Alexander, and et al. Effect of transgene copy number on survival in the G93A SOD1 transgenic mouse model of ALS Brain Res. Mol. Brain Res. 130 2004 7 15
57. K.A. Hanson, and et al. Ubiquilin modifies TDP-43 toxicity in a Drosophila model of amyotrophic lateral sclerosis (ALS) J. Biol. Chem. 285 2010 11068 11072
58. C.G. Tankersley, and et al. Respiratory impairment in a mouse model of amyotrophic lateral sclerosis J. Appl. Physiol. 102 2007 926 932
59. A. Stieber, and et al. Aggregation of ubiquitin and a mutant ALS-linked SOD1 protein correlate with disease progression and fragmentation of the Golgi apparatus J. Neurol. Sci. 173 2000 53 62
60. M. Watanabe, and et al. Histological evidence of protein aggregation in mutant SOD1 transgenic mice and in amyotrophic lateral sclerosis neural tissues Neurobiol. Dis. 8 2001 933 941
61. J.S. Prescott-Mathews, and et al. Methyl tert-butyl ether causes alpha2u-globulin nephropathy and enhanced renal cell proliferation in male Fischer-344 rats Toxicol. Appl. Pharmacol. 143 1997 301 314
62. D.R. Dietrich, and J.A. Swenberg The presence of alpha 2u-globulin is necessary for d-limonene promotion of male rat kidney tumors Cancer Res. 51 1991 3512 3521
63. P. Stuart, and G. Slavin Toxicity of penicillin to guinea pigs Nature 167 1951 319 320
64. I.D. Fratta, and et al. Teratogenic effects of thalidomide in rabbits, rats, hamsters, and mice Toxicol. Appl. Pharmacol. 7 1965 268 286
65. H. Schumacher, and et al. A comparison of the teratogenic activity of thalidomide in rabbits and rats J. Pharmacol. Exp. Ther. 160 1968 189 200
66. M. Martignoni, and et al. Species differences between mouse, rat, dog, monkey and human CYP-mediated drug metabolism, inhibition and induction Expert Opin. Drug Metab. Toxicol. 2 2006 875 894
67. A. Knight Systematic reviews of animal experiments demonstrate poor human clinical and toxicological utility Altern. Lab. Anim. 35 2007 641 659
68. F. Fang, and et al. Loss of a child and the risk of amyotrophic lateral sclerosis Am. J. Epidemiol. 167 2008 203 210
69. H. Wang, and et al. Vitamin E intake and risk of amyotrophic lateral sclerosis: a pooled analysis of data from 5 prospective cohort studies Am. J. Epidemiol. 173 2011 595 602
70. T. Godbey, and et al. Cage-change interval preference in mice Lab Anim. 40 2011 225 230
71. S.R. Milligan, and et al. Sound levels in rooms housing laboratory animals: an uncontrolled daily variable Physiol. Behav. 53 1993 1067 1076
72. I.A. Olsson, and K. Dahlborn Improving housing conditions for laboratory mice: a review of 'environmental enrichment' Lab Anim. 36 2002 243 270
73. C.J. Alves, and et al. Early motor and electrophysiological changes in transgenic mouse model of amyotrophic lateral sclerosis and gender differences on clinical outcome Brain Res. 1394 2011 90 104
74. C.J. Zeiss Neuroanatomical phenotyping in the mouse: the dopaminergic system Vet. Pathol. 42 2005 753 773
75. L. Moon, and M.B. Bunge From animal models to humans: strategies for promoting CNS axon regeneration and recovery of limb function after spinal cord injury J. Neurol. Phys. Ther. 29 2005 55 69
76. X.J. Chen, and et al. Neuroanatomical differences between mouse strains as shown by high-resolution 3D MRI Neuroimage 29 2006 99 105
77. A. Eisen Amyotrophic lateral sclerosis - evolutionary and other perspectives Muscle Nerve 40 2009 297 304
78. C. Stansberg, and et al. Gene expression in the rat brain: high similarity but unique differences between frontomedial-, temporal- and occipital cortex BMC Neurosci. 12 2011 15
79. A.C. Ludolph, and et al. Guidelines for preclinical animal research in ALS/MND: a consensus meeting Amyotroph. Lateral Scler. 11 2010 38 45
80. L. Van Den Bosch Genetic rodent models of amyotrophic lateral sclerosis J. Biomed. Biotechnol. 2011 2011 348765
81. S. Vinsant, and et al. Characterization of early pathogenesis in the SOD1(G93A) mouse model of ALS: part II, results and discussion Brain Behav. 3 2013 431 457
82. M. DeJesus-Hernandez, and et al. Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS Neuron 72 2011 245 256
83. F. Dangond, and et al. Molecular signature of late-stage human ALS revealed by expression profiling of postmortem spinal cord gray matter Physiol. Genomics 16 2004 229 239
84. E. Pupillo, and et al. Trauma and amyotrophic lateral sclerosis: a case-control study from a population-based registry Eur. J. Neurol. 19 2012 1509 1517
85. E. Beghi, and et al. The epidemiology and treatment of ALS: focus on the heterogeneity of the disease and critical appraisal of therapeutic trials Amyotroph. Lateral Scler. 12 2011 1 10
86. B.S. Johnson, and et al. A yeast TDP-43 proteinopathy model: exploring the molecular determinants of TDP-43 aggregation and cellular toxicity Proc. Natl. Acad. Sci. U. S. A. 105 2008 6439 6444
87. H. Suzuki, and et al. ALS-linked P56S-VAPB, an aggregated loss-of-function mutant of VAPB, predisposes motor neurons to ER stress-related death by inducing aggregation of co-expressed wild-type VAPB J. Neurochem. 108 2009 973 985
88. J. Wang, and et al. Protective effects of resveratrol through the up-regulation of SIRT1 expression in the mutant hSOD1-G93A-bearing motor neuron-like cell culture model of amyotrophic lateral sclerosis Neurosci. Lett. 503 2011 250 255
89. N.M. Boulis, and et al. Translational stem cell therapy for amyotrophic lateral sclerosis Nat. Rev. Neurol. 8 2011 172 176
90. M.E. Long Predicting carcinogenicity in humans: the need to supplement animal-based toxicology Altern. Anim. Test. Exp. 14 2007 553 559
91. A. Thomas, and et al. Quantitative analysis of gene expression in organotypic slice-explant cultures by particle-mediated gene transfer J. Neurosci. Methods 84 1998 181 191
92. C.E. Stokes, and et al. Dynamics of a transgene expression in acute rat brain slices transfected with adenoviral vectors Exp. Physiol. 88 2003 459 466
93. K.D. Foust, and et al. Therapeutic AAV9-mediated suppression of mutant SOD1 slows disease progression and extends survival in models of inherited ALS Mol. Ther. 21 2013 2148 2159
94. J.T. Dimos, and et al. Induced pluripotent stem cells generated from patients with ALS can be differentiated into motor neurons Science 321 2008 1218 1221
95. E. Kiskinis, and et al. Pathways disrupted in human ALS motor neurons identified through genetic correction of mutant SOD1 Cell Stem Cell 14 2014 781 795
96. N. Egawa, and et al. Drug screening for ALS using patient-specific induced pluripotent stem cells Sci. Transl. Med. 4 2012 145ra104
97. Y.M. Yang, and et al. A small molecule screen in stem-cell-derived motor neurons identifies a kinase inhibitor as a candidate therapeutic for ALS Cell Stem Cell 12 2013 713 726
98. B.J. Wainger, and et al. Intrinsic membrane hyperexcitability of amyotrophic lateral sclerosis patient-derived motor neurons Cell Rep. 7 2014 1 11
99. F. Fecto, and et al. SQSTM1 mutations in familial and sporadic amyotrophic lateral sclerosis Arch. Neurol. 68 2011 1440 1446
100. S.M. Elbasiouny, and et al. Evidence from computer simulations for alterations in the membrane biophysical properties and dendritic processing of synaptic inputs in mutant superoxide dismutase-1 motoneurons J. Neurosci. 30 2010 5544 5558
101. P. Origone, and et al. Fast course ALS presenting with vocal cord paralysis: clinical features, bioinformatic and modelling analysis of the novel SOD1 Gly147Ser mutation Amyotroph. Lateral Scler. 13 2012 144 148
102. Y. Zheng, and et al. The virtual NOD mouse: applying predictive biosimulation to research in type 1 diabetes Ann. N. Y. Acad. Sci. 1103 2007 45 62
103. L. Shoda, and et al. The Type 1 Diabetes PhysioLab Platform: a validated physiologically based mathematical model of pathogenesis in the non-obese diabetic mouse Clin. Exp. Immunol. 161 2010 250 267
104. A.A. Mamchak, and et al. Preexisting autoantibodies predict efficacy of oral insulin to cure autoimmune diabetes in combination with anti-CD3 Diabetes 61 2012 1490 1499
105. G.T. Ankley, and et al. Adverse outcome pathways: a conceptual framework to support ecotoxicology research and risk assessment Environ. Toxicol. Chem. 29 2010 730 741
106. A. del Sol, and et al. Diseases as network perturbations Curr. Opin. Biotechnol. 21 2010 566 571
107. H. Zhou, and et al. Transgenic rat model of neurodegeneration caused by mutation in the TDP gene PLoS Genet. 6 2010 e1000887